207 related articles for article (PubMed ID: 18577524)
21. Membrane receptors: structure and function of the relaxin family peptide receptors.
Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
[TBL] [Abstract][Full Text] [Related]
22. Secretory overexpression and isotopic labeling of the chimeric relaxin family peptide R3/I5 in Pichia pastoris.
Guo YQ; Wu QP; Shao XX; Shen T; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2015 Jun; 47(6):1117-25. PubMed ID: 25740604
[TBL] [Abstract][Full Text] [Related]
23. Single chain peptide agonists of relaxin receptors.
Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
[TBL] [Abstract][Full Text] [Related]
24. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4.
Praveen P; Bathgate RAD; Hossain MA
Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677
[TBL] [Abstract][Full Text] [Related]
25. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
[TBL] [Abstract][Full Text] [Related]
26. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species.
Chen J; Kuei C; Sutton SW; Bonaventure P; Nepomuceno D; Eriste E; Sillard R; Lovenberg TW; Liu C
J Pharmacol Exp Ther; 2005 Jan; 312(1):83-95. PubMed ID: 15367576
[TBL] [Abstract][Full Text] [Related]
28. Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3.
Rosengren KJ; Lin F; Bathgate RA; Tregear GW; Daly NL; Wade JD; Craik DJ
J Biol Chem; 2006 Mar; 281(9):5845-51. PubMed ID: 16365033
[TBL] [Abstract][Full Text] [Related]
29. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.
Liu C; Eriste E; Sutton S; Chen J; Roland B; Kuei C; Farmer N; Jörnvall H; Sillard R; Lovenberg TW
J Biol Chem; 2003 Dec; 278(50):50754-64. PubMed ID: 14522968
[TBL] [Abstract][Full Text] [Related]
30. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
[TBL] [Abstract][Full Text] [Related]
31. Coevolution of the relaxin-like peptides and their receptors.
Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the signaling system in relaxin-family peptides.
Hsu SY; Semyonov J; Park JI; Chang CL
Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
[TBL] [Abstract][Full Text] [Related]
33. Structural insights into the function of relaxins.
Rosengren KJ; Bathgate RA; Craik DJ; Daly NL; Haugaard-Jönsson LM; Hossain MA; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():20-6. PubMed ID: 19416153
[TBL] [Abstract][Full Text] [Related]
34. The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.
Patil NA; Bathgate RAD; Kocan M; Ang SY; Tailhades J; Separovic F; Summers R; Grosse J; Hughes RA; Wade JD; Hossain MA
Amino Acids; 2016 Apr; 48(4):987-992. PubMed ID: 26661035
[TBL] [Abstract][Full Text] [Related]
35. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
36. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
37. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
38. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
39. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
40. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
